Renal salt wasting as part of dysautonomia in Guillain-Barré syndrome

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 82, Issue 9, 2011, Pages 1051-1053

  Lenhard, Thorsten ^a   Grimm, C ^a   Ringleb, P A ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; AUTOANTIBODY; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM1 ANTIBODY; GANGLIOSIDE GM2 ANTIBODY; IMMUNOGLOBULIN; INFUSION FLUID; LIVER ENZYME; SODIUM; UNCLASSIFIED DRUG; URIC ACID;

AGED; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CONSTIPATION; DISEASE SEVERITY; DISORIENTATION; DRUG MEGADOSE; DYSAUTONOMIA; DYSPNEA; ELECTROPHYSIOLOGY; EPSTEIN BARR VIRUS INFECTION; FEMALE; FLUID THERAPY; FORCED VITAL CAPACITY; GAIT DISORDER; GUILLAIN BARRE SYNDROME; HEART RATE VARIABILITY; HUMAN; HYPONATREMIA; LEG PAIN; LEG WEAKNESS; LIMB WEAKNESS; LUMBAR PUNCTURE; MEAN ARTERIAL PRESSURE; MEDIAN NERVE; MICTURITION DISORDER; MOTOR DYSFUNCTION; NEUROLOGIC EXAMINATION; PERONEUS NERVE; POSTVOID RESIDUAL URINE VOLUME; PRIORITY JOURNAL; RENAL SALT WASTING; SALT WASTING; SODIUM EXCRETION; TACHYCARDIA; TENDON REFLEX; TIBIAL NERVE; URIC ACID URINE LEVEL; VITAL SIGN;

AGED; ALBUMINS; CONSTIPATION; DEMYELINATING DISEASES; ELECTROPHYSIOLOGICAL PHENOMENA; FEMALE; GAIT DISORDERS, NEUROLOGIC; GUILLAIN-BARRE SYNDROME; HUMANS; HYPONATREMIA; KIDNEY; PRIMARY DYSAUTONOMIAS; SODIUM; URINARY BLADDER; URINATION DISORDERS;

EID: 80051523983     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2009.192369     Document Type: Article

References (15)

1. Rabinstein AA, Wijdicks EF. Hyponatremia in critically ill neurological patients. Neurologist 2003;9:290-300. (Pubitemid 37484848)
2. Lenhard T, Bettendorf M, Schwab S. Disorders of salt and fluid balance: diabetes insipidus, cerebral salt-wasting syndrome, and syndrome of inappropriate antidiuresis. In: Donald W Pfaff, Arthur P Arnold, Anne M Etgen, et al, eds. Hormones, brain and behavior. 2nd edn. Vol 5. San Diego: Academic Press, 2009:3235-65.
3. Maesaka JK, Miyawaki N, Palaia T, et al. Renal salt wasting without cerebral disease: diagnostic value of urate determinations in hyponatremia. Kidney Int 2007;71:822-6. (Pubitemid 46624016)
4. Hochman MS, Kobetz SA, Handwerker JV. Inappropriate secretion of antidiuretic hormone associated with Guillain-Barré syndrome. Ann Neurol 1982;11:322-3.
5. van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol 2008;7:939-50.
6. Hughes RA, Raphael JC, Swan AV, et al. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev 2006;(1):CD002063.
7. Wijdicks EFM, Ropper AH, Hathanson JA. Atrial natriuretic factor and blood pressure fluctuations in Guillain-Barré Syndrome. Ann Neurol 1990;27:337.
8. Maesaka JK, Gupta S, Fishbane S. Cerebral RSW syndrome: does it exist? Nephron 1999;82:100-9. (Pubitemid 29263967)
9. Antunes-Rodrigues J, de Castro M, Elias LL, et al. Neuroendocrine control of body fluid metabolism. Physiol Rev 2004;84:169-208. (Pubitemid 38049879)
10. Lee YJ, Lin SR, Shin SJ, et al. Brain natriuretic peptide is synthesized in the human adrenal medulla and its messenger ribonucleic acid expression along with that of atrial natriuretic peptide are enhanced in patients with primary aldosteronism. J Clin Endocrinol Metab 1994;79:1476-82.
11. Taupenot L, Harper KL, O'Connor DT. The chromogranin-secretogranin family. N Engl J Med 2003;348:1134-49. (Pubitemid 36337325)
12. Steiner HJ, Weiler R, Ludescher C, et al. Chromogranins A and B are co-localized with atrial natriuretic peptides in secretory granules of rat heart. J Histochem Cytochem 1990;38:845-50. (Pubitemid 20177852)
13. Totsune K, Takahashi K, Murakami O, et al. Immunoreactive brain natriuretic peptide in human adrenal glands and adrenal tumors. Eur J Endocrinol 1996;135:352-6. (Pubitemid 26348741)
14. Lenhard T, Külkens S, Schwab S. Cerebral salt-wasting syndrome in a patient with neuroleptic malignant syndrome. Arch Neurol 2007;64:122-5. (Pubitemid 46072434)
15. Gurrera RJ. Sympathoadrenal hyperactivity and the etiology of neuroleptic malignant syndrome. Am J Psychiatry 1999;156:169-80. (Pubitemid 29077106)